Dyne Therapeutics Files Form 4 on Ownership Changes

Ticker: DYN · Form: 4 · Filed: Apr 22, 2026 · CIK: 0001818794

Dyne Therapeutics, INC. 4 Filing Summary
FieldDetail
CompanyDyne Therapeutics, INC. (DYN)
Form Type4
Filed DateApr 22, 2026
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: insider-filing, ownership-change

TL;DR

Dyne Therapeutics filed a Form 4 on 4/22/26 for ownership changes on 4/20/26.

AI Summary

On April 22, 2026, Dyne Therapeutics, Inc. filed a Form 4, reporting changes in beneficial ownership of securities. The filing details transactions that occurred on April 20, 2026. The report was accepted by the SEC on April 22, 2026.

Why It Matters

Form 4 filings are crucial for investors as they disclose changes in stock ownership by company insiders, providing insights into their confidence in the company's prospects.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of ownership changes and does not inherently indicate new risks for the company.

Key Numbers

Key Players & Entities

FAQ

What type of transaction is being reported in this Form 4?

The filing is a Statement of changes in beneficial ownership of securities.

Who is the issuer of this filing?

The issuer is Dyne Therapeutics, Inc.

When was the filing accepted by the SEC?

The filing was accepted on 2026-04-22.

What is the CIK number for Dyne Therapeutics, Inc.?

The CIK number for Dyne Therapeutics, Inc. is 0001818794.

What is the period of report for this filing?

The period of report is 2026-04-20.

Filing Details

This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 22, 2026 by Rhodes Jason P regarding Dyne Therapeutics, Inc. (DYN). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.

View full filing on EDGAR

View Full Filing

View this 4 filing on SEC EDGAR

View on Read The Filing